Monthly information on share capital and company voting rights
Rhea-AI Summary
Positive
- None.
Negative
- None.
News Market Reaction – CLLS
On the day this news was published, CLLS declined 2.08%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, June 05, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 05/31/2025 | 100,325,229 | 89,110,384 |
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Attachment
FAQ
What is the current total number of shares in Cellectis (CLLS) as of May 2025?
How many voting rights does Cellectis (CLLS) have as of May 2025?
Where is Cellectis (CLLS) stock listed?
What is the difference between Cellectis total shares and voting rights in May 2025?